What Are the Stages of Endometrial Cancer?
Endometrial cancer is classified into endometrial cancer stages 1, 2, 3, and 4 using the International Federation of Gynecology and Obstetrics (FIGO) staging system. This defines a universal terminology that allows physicians to describe the condition precisely and unambiguously. Staging offers additional benefits in clinical trials, such as facilitating patient pooling, improving disease prognosis, enabling all institutions to adopt the same management plans, and supporting future management and outcome assessment.
How Do Doctors Determine Endometrial Cancer Stage?
The endometrial cancer stage is determined by how far the cancer has spread within and outside of the uterus. Doctors examine whether it has reached local organs, tissues, or other parts of the body. Other factors considered include the aggressiveness of cancer cells and the rate of tumor growth. Once all this information has been obtained, doctors will assign a stage using the FIGO staging system, which will guide treatment strategy and indicate prognosis.
Tests Used for Staging
1. Endometrial Biopsy
Under a microscope, a sample of the lining of the uterus is examined.
This assesses the presence of cancer and helps determine its type.
2. CT and MRI Scans
Magnetic resonance imaging (MRI) provides finely detailed pictures of the uterus and its surrounding tissues.
The computed tomography (CT) scans determine whether cancer has spread to lymph nodes or other organs.
Both are non-invasive methods for locating the tumor.
3. Surgical Method:
The surgical method frequently involves the removal of the uterus (hysterectomy), fallopian tubes, and, in some cases, the ovaries.
The degree of cancer infiltration into the wall of the uterus and surrounding tissues is apparent with direct surgical inspection.
This method is considered the most accurate staging technique.
4. Lymph Node Evaluation
A tiny sample of lymph nodes near the uterus is examined to determine whether cancer has progressed outside the uterus, which helps in treatment planning.
Overview of Endometrial Cancer Stages
The stages of endometrial cancer are used to explain the disease's spread throughout the body. To standardize diagnosis and guide clinical decisions, physicians use the FIGO staging system to organize data into distinct categories.
1. Stage 1 Endometrial Cancer
Cancer is limited to the uterus.
Stage 1A: Only affects the inner lining (endometrium) or less than half of the muscle wall.
Stage 1B: It invades more than 50 % of the uterine muscle.
According to the survival rate for stage 1 endometrial cancer, this is the earliest stage of the disease and frequently offers the best prognosis.
2. Stage 2 Endometrial Cancer
The cancer is still inside the uterus but has progressed to the cervix.
3. Stage 3 Endometrial Cancer
At this stage, cancer is still present in the pelvic area, and it spreads both locally and regionally.
It may spread outside of the uterus during this stage without impacting distant organs.
Stage 3A: Spreads to nearby tissues or the outside of the uterus.
Stage 3B: Spread to the supporting structures of the vagina.
Stage 3C: Lymph nodes in the pelvis or para-aortic area are involved.
Patients may have pelvic pain or irregular bleeding as symptoms of stage 3 endometrial cancer.
4. Stage 4 Endometrial Cancer
Stage IV is characterized by being the most advanced and aggressive form of endometrial cancer and thus has a poor prognosis. At this stage of endometrial cancer, the cancer has spread past the pelvic region into organs farther away.
Stage 4A: Infiltrates nearby organs, like the colon or bladder.
Stage 4B: Metastasis (spread) to bone, liver, or lungs.
Staging of endometrial cancer to stage IV implies that there is a poor prognosis
What Are the Endometrial Cancer Stage Survival Rates?
Endometrial cancer survival rates indicate how likely it is that patients will live for a given amount of time (usually five years) after receiving a diagnosis. The stage of the cancer at the time of finding determines the rates.
Rates of survival by stage during the five years are as follows:
1. Stage I: Approximately 80 to 90%
Early detection of cancer makes it highly curable.
2. Stage II: Approximately 70 to 80%
Treatment is still effective, even though the cancer has spread marginally.
3. Stage III: Approximately 40 to 60%
Further dissemination of cancer has occurred in the pelvic region. The treatment is usually surgical removal of the uterus and the diseased tissues, often followed by radiation, chemotherapy, or combined treatment for remaining cancerous cells. The outlook is considered fair, with results based on metastatic stage, tumor type, and treatment response.
4. Stage IV: Approximately 15 to 20%
The treatment of cancer has become more difficult due to its dissemination to remote regions of the body.
Conclusion
The stage of endometrial cancer refers to how far the cancer has spread within the uterus and to other organs. Healthcare professionals use staging to find out how severe the cancer is, what the best form of treatment will be, and how the disease will change over time. Early detection and staging of endometrial cancer increases the likelihood of the disease being treated effectively, and knowing the stage of the cancer allows the patient to receive the best possible care and make informed decisions. It is advised that you speak with a cancer specialist if you have been diagnosed with endometrial cancer to guide your care and treatment.
Key Takeaways
The stage of endometrial cancer refers to the extent of the disease, either within or beyond the uterus.
Staging accuracy is vital for predicting disease behavior and selecting appropriate treatment.
Stage 4 reflects the requirement for aggressive treatment approaches due to progression to distant sites.
The application of FIGO staging enables doctors across institutions to adhere to similar treatment protocols and accurately measure their efficacy.
